Aclaris Reports 2025 Financial Results and Clinical Trial Updates
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) reported its financial results for the fourth quarter and full year of 2025 and provided updates on several clinical-stage drug development programs, …
Aclaris Reports 2025 Financial Results and Clinical Trial Updates Read More